Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001724521-26-000034
Filing Date
2026-05-05
Accepted
2026-05-05 16:11:52
Documents
76
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rcus-20260331.htm   iXBRL 10-Q 1096679
2 EX-10.1 ex101.htm EX-10.1 44103
3 EX-31.1 a2026q1exhibit311.htm EX-31.1 10357
4 EX-31.2 a2026q1exhibit312.htm EX-31.2 10374
5 EX-32.1 a2026q1exhibit321.htm EX-32.1 4671
6 EX-32.2 a2026q1exhibit322.htm EX-32.2 4679
12 rcus-20260331_g1.jpg GRAPHIC 191973
  Complete submission text file 0001724521-26-000034.txt   6370781

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rcus-20260331.xsd EX-101.SCH 53266
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rcus-20260331_cal.xml EX-101.CAL 57667
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rcus-20260331_def.xml EX-101.DEF 211265
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rcus-20260331_lab.xml EX-101.LAB 540864
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rcus-20260331_pre.xml EX-101.PRE 380497
80 EXTRACTED XBRL INSTANCE DOCUMENT rcus-20260331_htm.xml XML 676870
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

EIN.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38419 | Film No.: 26943242
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)